United States Hereditary Genetic Testing Market – Size, Share, and Growth Analysis – Techsci Research

According to a report by TechSci Research, titled “United States Hereditary Genetic Testing Market –By Region, Competition Forecast, & Opportunities, 2018-2028,” the United States hereditary genetic testing market is expected to grow at a steady rate between 2024 and 2028. This growth can be attributed to the increasing prevalence of genetic disorders such as cystic fibrosis and sickle cell disease, as well as an increase in cancer cases and genetic anomalies in newborns across the country. Additionally, growing awareness of genetic testing for cancer screening and prenatal genetic screening, as well as the increasing use of next-generation sequencing (NGS) for studying various genetic diseases, will drive market growth during this period. The growing healthcare infrastructure and government support for diagnosing genetic diseases are also expected to create lucrative growth opportunities. Technological advancements such as chromosomal microarray analysis and biochips for detecting genetic disorders are also anticipated to boost market growth.

However, several factors may hinder the growth of the United States hereditary genetic testing market. Standardization concerns for genetic testing-based diagnostics may hamper market growth. Additionally, stringent regulatory requirements for product approvals in regions such as North America and South America may restrict market expansion. The high cost of DNA testing kits may also hinder market growth. Furthermore, a lack of skilled professionals in laboratories to manage DNA analysis techniques may limit market expansion over the years.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "United States Hereditary Genetic Testing Market” - https://www.techsciresearch.com/report/united-states-hereditary-genetic-testing-market/14825.html

United States Hereditary Genetic Testing Market can be segmented by technique, application, payer, end user, region and competitive landscape.

The United States hereditary genetic testing market can be segmented based on technique, application, payer, end-user, region, and competitive landscape. In terms of technique, the market can be segmented into PCR, DNA sequencing, microarrays, and others. The DNA sequencing segment is expected to dominate the market during the forecast period due to the growing adoption of this technique for conducting genetic tests. Additionally, the increasing demand for faster analysis techniques and decreasing costs of next-generation sequencing (NGS) are expected to support segment growth. The growing detection of mutations in genes is also an important component of oncology genetic testing and will drive market growth during this period.

In terms of application, the United States hereditary genetic testing market can be further segmented into cardiology, oncology, pharmacogenomics, cognitive dysfunction, pathogenomics, and others. The oncology segment dominated the market in 2022 and is expected to maintain its dominance throughout the forecast period. This dominance can be attributed to the launch of new and technologically advanced genetic tests by key players, favorable reimbursement policies, and growing demand for better diagnosis due to the increasing incidence of cancer across the country.

Major companies operating in the United States Hereditary Genetic Testing Market are:

• Invitae Corporation
• Ambry Genetics
• BioReference Laboratories Inc.
• Progenity Inc.
• Pathema Gx Labs, LLC.
• Quest Diagnostics Incorporated
• Myriad Genetics Inc.
• Fulgent Genetics, Inc.
• Burning Rock Biotech Limited.

 

In March 2021, GI OnDEMAND announced a collaborated with Ambry Genetics to integrate online genetic counseling and testing services into their nationwide gastroenterology practices and it can identify hereditary GI cancer syndromes to guide through potentially life-altering healthcare decisions.

 

Download Free Sample Report

Customers can also request for 10% free customization on this report.

 

“United States Hereditary Genetic Testing Market is expected to register significant growth during the forecast period on account of the increasing demand for accurate and reliable data along with the growing adoption of advanced testing techniques across the country. Similarly, the growing prevalence of chronic diseases such as cardiovascular diseases, cancer, and other genetic diseases will further drive the growth of the market during the forecast period. Additionally, the growing demand for early and preventive care along with growing awareness about DNA sequencing techniques among researchers and laboratory technicians is expected to drive the growth of the market over the years. Besides, the presence of key players providing the genetic tests, growing recommendations provided by government agencies to ensure the quality of hereditary testing services is further expected to increase the demand for  hereditary genetic testing market in the US.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

“United States Hereditary Genetic Testing Market By Technique (PCR, DNA Sequencing, Microarrays, Others), By Application (Cardiology, Oncology, Pharmacogenomics, Cognitive Dysfunction, Pathogenomics, Others), By Payer (Public Health Insurance, Private Health Insurance, Out of Pocket), By End User (Hospitals, Independent Laboratories), By Region, Competition Forecast & Opportunities, 2018-2028F,” has evaluated the future growth potential of United States Hereditary Genetic Testing Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in United States Hereditary Genetic Testing market.

Table Of Content –

1. Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.     Markets Covered

1.2.2.     Years Considered for Study

1.2.3.     Key Market Segmentations

2. Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3. Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4. Voice of Customer
5. United States Hereditary Genetic Testing Market Outlook

5.1.  Market Size & Forecast

5.1.1.     By Value

5.2.  Market Share & Forecast

5.2.1.     By Technique (PCR, DNA Sequencing, Microarrays, Others)

5.2.2.     By Application (Cardiology, Oncology, Pharmacogenomics, Cognitive Dysfunction, Pathogenomics, Others)

5.2.3.     By Payer (Public Health Insurance, Private Health Insurance, Out of Pocket)

5.2.4.     By End User (Hospitals, Independent Laboratories)

5.2.5.     By Region

5.2.6.     By Company (2022)

5.3.  Market Map

5.3.1.     By Technique

5.3.2.     By Application

5.3.3.     By Payer

5.3.4.     By End User

5.3.5.     By Region

6. North-East United States Hereditary Genetic Testing Market Outlook

6.1.  Market Size & Forecast          

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Technique

6.2.2.     By Application

6.2.3.     By Payer

6.2.4.     By End User

7. Mid-West United States Hereditary Genetic Testing Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Technique

7.2.2.     By Application

7.2.3.     By Payer

7.2.4.     By End User

………………….. continued

Download Free Sample Report - https://www.techsciresearch.com/sample-report.aspx?cid=14825

About TechSci Research:

TechSci Research is a research-based management consulting firm providing market research and advisory solutions to its customers worldwide, spanning a range of industries. TechSci Research’s core values are value, integrity and insight. Led by a team of dynamic industry experts, TechSci Research provides its customers with high value market research and advisory services that helps them identify new market opportunities, growth engines and innovative ways to capture the market share. As a result, TechSci’s client leads rather than follow market trends. Not bound by legacy, TechSci’s cutting-edge research model leverages its decades of research knowledge and an increased use of technology as engines of innovation to deliver unique research value. Provided as an alternative to traditional market research, TechSci Research reports do not just deliver data and knowledge rather highlights the insights in a more usable and interactive format for its clients.

 

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: [email protected]

Web: https://www.techsciresearch.com